GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection.

Saved in:
Bibliographic Details
Place / Publishing House:Geneva : : World Health Organization,, 2023.
©2023.
Year of Publication:2023
Edition:1st ed.
Language:English
Online Access:
Physical Description:1 online resource (72 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03684nam a22003493i 4500
001 50030733622
003 MiAaPQ
005 20240229073851.0
006 m o d |
007 cr cnu||||||||
008 240229s2023 xx o ||||0 eng d
020 |a 9789240076600  |q (electronic bk.) 
035 |a (MiAaPQ)50030733622 
035 |a (Au-PeEL)EBL30733622 
035 |a (OCoLC)1396699152 
040 |a MiAaPQ  |b eng  |e rda  |e pn  |c MiAaPQ  |d MiAaPQ 
245 1 0 |a GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. 
250 |a 1st ed. 
264 1 |a Geneva :  |b World Health Organization,  |c 2023. 
264 4 |c ©2023. 
300 |a 1 online resource (72 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting. 
505 8 |a References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators. 
588 |a Description based on publisher supplied metadata and other sources. 
590 |a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.  
655 4 |a Electronic books. 
776 0 8 |i Print version:  |t GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection  |d Geneva : World Health Organization,c2023 
797 2 |a ProQuest (Firm) 
856 4 0 |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=30733622  |z Click to View